New opioid analgesic tapentadol in the treatment of neuropathic pain in oncology

Abstract

Famous and familiar analgesics are being replaced by new drugs with improved properties. How to calculate their dose, in which category of patients to use, for what type of pain, with what dose to start therapy and with what adjuvants to combine? Many questions arise when a new opioid is being used. To answer these difficult questions, we decided to share our experience with the new analgesic tapentadol, describing real clinical cases from our practice.

Keywords

• oncology
• pain management
• opioid analgesics
• neuropathic pain